论文部分内容阅读
高红细胞压积的急性脑梗塞患者红细胞单采＋传统疗法组（红细胞单采组）31例，传统疗法组（对照组）33冽。两组年龄、发病至开始治疗时间、治疗前神经功能缺损积分和既往史积分比较无显著性差异，伴发病积分红细胞单采组高于对照组。治疗三周后两组Hct和神经功能缺损积分减少差值有显著性差异（P＜0．05）。提示红细胞单采组疗效优于对照组。证明红细胞单采对急性脑梗塞患者近期疗效肯定。
There were 31 cases of erythrocyte apheresis + traditional therapy group (erythrocyte apheresis group) in patients with high hematocrit of acute cerebral infarction, and 33 cases in the traditional therapy group (control group). Two groups of age, onset to treatment time, before treatment, neurological deficit score and past history score no significant difference, with the disease score erythrocyte apheresis group was higher than the control group. Three weeks after treatment, there was a significant difference (P <0.05) in the difference between Hct and neurological deficit scores. Prompt erythrocyte apheresis group is better than the control group. Prove that a single harvest of red blood cells in patients with acute cerebral infarction in the near future effect.